Etizolam + Escitalopram Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: Etizolam(0.25 mg-0.5 mg) + Escitalopram( 5 -10 mg)
Reference Brands: Etizola Plus, Nexito Plus, Stalopam Plus(India & in Asia)
Category:
Antipsychotropic Drugs
Etizolam + Escitalopram tablets are used to treat anxiety with depression. Though not approved in the US/EU, they are popular in Asia. Common strengths include Etizolam 0.5 mg + Escitalopram 10 mg. Ideal for B2B pharma buyers targeting mental health markets with neuropsychiatric product portfolios.
Etizolam + Escitalopram is available in Tablets
and strengths such as Etizolam(0.25 mg-0.5 mg) + Escitalopram( 5 -10 mg).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Etizolam + Escitalopram is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Etizolam + Escitalopram can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Etizolam + Escitalopram is a fixed-dose combination used in the treatment of anxiety disorders with comorbid depression. Etizolam, a fast-acting anxiolytic, complements Escitalopram, a selective serotonin reuptake inhibitor (SSRI), to provide comprehensive relief from mood and anxiety symptoms. Though not approved in the US or EU due to regulatory classifications, this combination is widely prescribed in India and other Asian markets. It is typically available in tablet form in strengths like Etizolam 0.25/0.5 mg with Escitalopram 5/10 mg. B2B pharmaceutical suppliers often cater this formulation to psychiatrists, hospitals, and wellness clinics targeting neuropsychiatric care markets
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing